Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma

Figure 5

Distribution patterns of the low-risk and high-risk groups. PCA between low-risk and high-risk groups on the basis of (a) the nine immune-related lncRNAs signature, (b) the whole genome expression profile, and (c) the immune-related lncRNA expression.

(a)

(b)

(c)